Detection of biological macromolecules by NMR-sensitive labels

• US 5,338,687 A
• Filed: 09/11/1992
• Issued: 08/16/1994
• Est. Priority Date: 09/11/1992
• Status: Expired due to Fees

• Current Assignee: James Gautsch, Lawrence L. Lee
• Original Assignee: James Gautsch, Lawrence L. Lee
• Inventors: Lee, Lawrence L., Gautsch, James
• Primary Examiner(s): Housel, James C.
• Assistant Examiner(s): Soderquist, Arlen
• Application Number:
  US07/943,552
• Time in Patent Office: 704 Days
• Field of Search: 324/300, 324/307, 204/299 R, 204/82.8, 204/180.13, 436/173, 436/94, 436/56
• US Class Current: 436/173
• CPC Class Codes: G01R 33/465 applied to biological material, e.g. in vitro testing
• CPC Class Codes: Y10T 436/13 Tracers or tags
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]
• CPC Class Codes: Y10T 436/24 Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Abstract

An apparatus and method for identifying the presence of biological molecules labeled with isotopes that are identifiable and distinguishable by their responses to nuclear magnetic resonance. The method features the use of labels that are:

1) not radioactive or only weakly radioactive, therefore not hazardous to handle, and have a long storage life.

2) small in molecular weight, thus not significantly changing the electrophoresis migration rate of the labeled material.

3) available as several distinguishable labels, thereby enabling simultaneous detection of several classes of molecules.

Claims

1. An apparatus for detecting electrophoretically separated biological molecules having at least one nuclear magnetic resonance-sensitive isotope comprising:

a) a magnet for providing a magnetic field of at least 1000 gauss at a predetermined sample area;

b) excitation means for exciting at least three nuclear magnetic resonance-sensitive isotopes of said separated biological molecules at said predetermined sample area;

c) detection means for detecting and identifying which of said at least three nuclear magnetic resonance-sensitive isotopes are present in the separated biological molecules at said predetermined sample area; and

d) an electrophoresis column positioned to deliver the separated biological molecules to the sample area where at least one nuclear magnetic-sensitive isotope is subjected to the magnetic field of the magnet, excited by the excitation means, and detected and identified by the detection means.

2. An apparatus according to claim 1 wherein said excitation means comprises radio frequency source means for exciting said at least three nuclear magnetic resonance-sensitive isotopes.

3. An apparatus according to claim 2 wherein said at least three nuclear magnetic resonance-sensitive isotopes comprise hydrogen-3, fluorine-19, and phosphorus-31.

4. An apparatus according to claim 1 wherein said detection means comprises radio frequency receiver means tuned to frequencies for detecting said at least three nuclear magnetic resonance-sensitive isotopes.

5. An apparatus according to claim 4 wherein said at least three nuclear magnetic resonance-sensitive isotopes comprise hydrogen-3, fluorine-19, and phosphorus-31.

6. A method for use with electrophoresis to analyze a mixture of biological molecules comprising the steps of:

a) labeling said mixture of biological molecules with nuclear magnetic resonance-sensitive isotopes such that the biological molecules have at least one of at least three nuclear magnetic resonance-sensitive isotopes;

b) separating said mixture of biological molecules on an electrophoresis column to form bands of separated biological molecules;

c) exposing said separated biological molecules to a magnetic field of at least 1000 gauss;

d) providing means for exciting each of said at least three nuclear magnetic resonance-sensitive isotopes while said separated biological molecules are in said magnetic field; and

e) detecting and identifying which of said at least three nuclear magnetic resonance-sensitive isotopes are present in the separated biological molecules in said magnetic field.

7. The method according to claim 6 wherein said at least three nuclear magnetic resonance-sensitive isotopes comprise hydrogen-3, fluorine-19, and phosphorus-31.

8. The method according to claim 6 wherein said biological molecules are chosen from the group consisting of ribonucleic acid and deoxyribonucleic acid.

9. The method according to claim 6 wherein said biological molecules are nucleic acid fragments having at least one phosphorus-31 atom as a nuclear magnetic resonance-sensitive isotope, each of said nucleic acid fragments having one of four different nucleotide bases at the termination of said fragments;

and wherein the step of labeling comprises attaching up to two additional nuclear magnetic resonance-sensitive isotopes, selected from the group consisting of hydrogen-3 and fluorine-19, to said four different nucleotide bases at the termination of said fragments to distinguish between the four different nucleotide bases at the termination of said fragments.

10. The method according to claim 6 wherein said biological molecules are nucleic acid fragments, each of said nucleic acid fragments having one of four different nucleotide bases at the termination of said fragments;

and wherein after the step of labeling the four different nucleotide bases at the termination of said fragments are distinguished by phosphorus-31 being the nuclear magnetic resonance-sensitive isotope of a first of said four different nucleotide bases, hydrogen-3 and phosphorus-31 being the nuclear magnetic resonance-sensitive isotopes of a second of said four different nucleotide bases, fluorine-19 and phosphorus-31 being the nuclear magnetic resonance-sensitive isotopes of a third of said four different nucleotide bases, and hydrogen-3, fluorine-19 and phosphorus-31 being the nuclear magnetic resonance-sensitive isotopes of a forth of said four different nucleotide bases.